The p21 Ser31Arg polymorphism and breast cancer risk: A meta-analysis involving 51,236 subjects

Breast Cancer Research and Treatment

Volumn 124, Issue 2, 2010, Pages 475-479

  Qiu, Li Xin ^a   Zhang, Jian ^a   Zhu, Xiao Dong ^a   Zheng, Chun Lei ^a   Sun, Si ^a   Wang, Zhong Hua ^a   Zhao, Xin Min ^a   Wang, Jia Lei ^a   Wang, Lei Ping ^a   Yu, Hui ^a   Xue, Kai ^a   Hu, Xi Chun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Breast cancer; Meta analysis; P21; Polymorphism; Susceptibility

Indexed keywords

ARGININE; PROTEIN P21; SERINE;

ACCURACY; ARTICLE; BREAST CANCER; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS;

EID: 78649320168     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-0858-3     Document Type: Article

References (20)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 15761078
2. PD Pharoah AM Dunning BA Ponder DF Easton 2004 Association studies for finding cancer-susceptibility genetic variants Nat Rev Cancer 4 850 860 1:CAS:528:DC%2BD2cXptFegt74%3D 10.1038/nrc1476 15516958 (Pubitemid 39472952)
3. Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC (2009) Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0636-2
4. Qiu LX, Yao L, Yuan H, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC (2010) IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls. Breast Cancer Res Treat. doi: 10.1007/s10549-010-0739-9
5. LX Qiu B Chen C Mao P Zhan H Yuan K Xue J Li XC Hu 2009 STK15 F31I polymorphism is associated with breast cancer risk: a meta-analysis involving 25, 014 subjects Breast Cancer Res Treat 118 599 603 1:CAS:528: DC%2BD1MXhtlyls7%2FI 10.1007/s10549-009-0574-z
6. AL Gartel SK Radhakrishnan 2005 Lost in transcription: p21 repression, mechanisms, and consequences Cancer Res 65 3980 3985 1:CAS:528: DC%2BD2MXktlSms7c%3D 10.1158/0008-5472.CAN-04-3995 15899785 (Pubitemid 40775632)
7. S Mousses H Ozcelik PD Lee D Malkin SB Bull IL Andrulis 1995 Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer Hum Mol Genet 4 1089 1092 1:CAS:528:DyaK2MXmtFeqtrc%3D 10.1093/hmg/4.6.1089 7655464
8. J Lukas S Groshen B Saffari 1997 WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium Am J Pathol 150 167 175 1:CAS:528:DyaK2sXoslWqsQ%3D%3D 9006333
9. The MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (2009) Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women. Breast Cancer Res Treat. doi: 10.1007/s10549-009-0489-8
10. H Ma G Jin Z Hu X Zhai W Chen S Wang 2006 Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women Int J Cancer 119 2173 2178 1:CAS:528:DC%2BD28XhtVSksL7E 10.1002/ijc.22094 16804901 (Pubitemid 44423677)
11. VA Tarasov MM Aslanyan ES Tsyrendorzhiyeva SS Litvinov RF Gar'kavtseva YP Altukhov 2006 Genetically determined subdivision of human populations with respect to the risk of breast cancer in women Dokl Biol Sci 406 66 69 1:STN:280:DC%2BD287nvFWhsg%3D%3D 10.1134/S0012496606010182 16572816
12. C Keshava BL Frye MS Wolff EC McCanlies A Weston 2002 Waf-1 (p21) and p53 polymorphisms in breast cancer Cancer Epidemiol Biomarkers Prev 11 127 130 1:CAS:528:DC%2BD38XhvFGiur8%3D 11815410 (erratum in: Cancer Epidemiol Biomarkers Prev 2004;13:1682)
13. A Cox AM Dunning M Garcia-Closas 2007 A common coding variant in CASP8 is associated with breast cancer risk Nat Genet 39 352 358 1:CAS:528: DC%2BD2sXitVOktrY%3D 10.1038/ng1981 17293864 (Pubitemid 46328496)
14. WG Cochran 1954 The combination of estimates from different experiments Biometrics 10 101 129 10.2307/3001666
15. N Mantel W Haenszel 1959 Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 719 748 1:STN:280:DyaG1M%2FosVOhtQ%3D%3D 13655060
16. R DerSimonian N Laird 1986 Meta-analysis in clinical trials Control Clini Trials 7 177 188 1:STN:280:DyaL2s7gsVamtA%3D%3D 10.1016/0197-2456(86)90046-2 (Pubitemid 17189972)
17. A Tobias 1999 Assessing the influence of a single study in the meta-analysis estimate Stata Tech Bull 8 15 17
18. M Egger G Davey Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test BMJ 315 629 634 1:STN:280: DyaK2svls1KjtA%3D%3D 9310563
19. JN Hirschhorn K Lohmueller E Byrne 2002 A comprehensive review of genetic association studies Genet Med 4 45 61 1:CAS:528:DC%2BD38XjtFSru7w%3D 10.1097/00125817-200203000-00002 11882781 (Pubitemid 44698579)
20. S Wacholder S Chanock M Garcia-Closas 2004 Assessing the probability that a positive report is false: an approach for molecular epidemiology studies J Natl Cancer Inst 96 434 442 10.1093/jnci/djh075 15026468